Viewing Study NCT05763459


Ignite Creation Date: 2025-12-24 @ 3:04 PM
Ignite Modification Date: 2025-12-27 @ 12:17 AM
Study NCT ID: NCT05763459
Status: COMPLETED
Last Update Posted: 2023-06-26
First Post: 2023-02-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Study of ABBV-CLS-7262, Rosuvastatin, and Digoxin in Healthy Subjects
Sponsor: Calico Life Sciences LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module